Abstract
Although the cyanobacteria/BMAA hypothesis of the cause of ALS and other age-related neurodegenerative diseases remains to be proven, it is not too early to ask whether treatment would be possible if the hypothesis were correct. This paper reviews the possible ways that chronic BMAA neurotoxicity could be prevented or treated.
Original language | English (US) |
---|---|
Pages (from-to) | 118-123 |
Number of pages | 6 |
Journal | Amyotrophic Lateral Sclerosis |
Volume | 10 |
Issue number | SUPPL. 2 |
DOIs | |
State | Published - 2009 |
Keywords
- Aminoacyl-tRNA synthetase
- Amyotrophic lateral sclerosis (ALS)
- Blood-brain barrier
- BMAA
- Therapeutic trial
ASJC Scopus subject areas
- Clinical Neurology
- Neurology